Monthly or even quarterly depot injections of GLP-1 agonists are in development
[11] As the condition progresses, the immune system response becomes increasingly dysfunctional
In parallel, antimicrobial peptides targeting fungal-specific enzymes, such as chitin synthase, along with other innovative small molecules, are also under active investigation ( Figure 4 ) (Ran et al., 2024)
Biochemistry, physiology and biotechnology of sulfate-reducing bacteria
These conditions preserve molecular integrity and ensure reliable results during long-term research use
The primary antibodies used were goat anti-DCX (1:500 dilution, catalog #sc-8066, Santa Cruz Biotechnology) and mouse anti-activity-regulated cytoskeleton-associated protein (Arc